Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain
Public ClinicalTrials.gov record NCT02324270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Multiple-Center, Placebo-Controlled Study Comparing the Safety and Efficacy of Generic Diclofenac Epolamine to Flector® Patch in the Treatment of Acute Pain Due to Minor Ankle Sprain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To demonstrate the therapeutic efficacy of a generic diclofenac epolamine patch against Flector patch in the treatment of pain in subjects with minor ankle sprain
Study identification
- NCT ID
- NCT02324270
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 658 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Type not available)
- Primary completion
- Dec 2014 (Actual)
- Completion
- Dec 2014 (Actual)
- Last update posted
- Jun 24, 2020
2014
United States locations
- U.S. sites
- 31
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 21 | Birmingham | Alabama | 35209 | — |
| Site 24 | Goodyear | Arizona | 85395 | — |
| Site 08 | Carlsbad | California | 92008 | — |
| Site 05 | Ventura | California | 93003 | — |
| Site 16 | Clinton | Connecticut | 84105 | — |
| Site 03 | Riverton | Connecticut | 84065 | — |
| Site 11 | Daytona Beach | Florida | 32117 | — |
| Site 09 | DeLand | Florida | 32720 | — |
| Site 14 | Miami | Florida | 33144 | — |
| Site 07 | Miami | Florida | 33155 | — |
| Site 13 | Miami | Florida | 33155 | — |
| Site 02 | West Palm Beach | Florida | 33409 | — |
| Site 26 | Lexington | Kentucky | 40509 | — |
| Site 12 | Gretna | Louisiana | 70056 | — |
| Site 23 | Kalamazoo | Michigan | 85395 | — |
| Site 41 | Traverse City | Michigan | 49684 | — |
| Site 10 | Omaha | Nebraska | 32117 | — |
| Site 29 | Berlin | New Jersey | 08009 | — |
| Site 18 | Brooklyn | New York | 11201 | — |
| Site 19 | Cincinnati | Ohio | 45246 | — |
| Site 30 | Columbus | Ohio | 43214 | — |
| Site 35 | Oklahoma City | Oklahoma | 73112 | — |
| Site 37 | Downingtown | Pennsylvania | 19355 | — |
| Site 27 | State College | Pennsylvania | 16801 | — |
| Site 15 | Austin | Texas | 78756 | — |
| 04 | El Paso | Texas | 93003 | — |
| Site 34 | Houston | Texas | 77089 | — |
| Site 36 | Lake Jackson | Texas | 77566 | — |
| Site 22 | San Antonio | Texas | 78218 | — |
| Site 31 | Danville | Virginia | 24541 | — |
| Site 06 | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02324270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02324270 live on ClinicalTrials.gov.